TITLE

Re-Annotator: Annotation Pipeline for Microarray Probe Sequences

AUTHOR(S)
Arloth, Janine; Bader, Daniel M.; Röh, Simone; Altmann, Andre
PUB. DATE
October 2015
SOURCE
PLoS ONE;10/1/2015, Vol. 10 Issue 10, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Microarray technologies are established approaches for high throughput gene expression, methylation and genotyping analysis. An accurate mapping of the array probes is essential to generate reliable biological findings. However, manufacturers of the microarray platforms typically provide incomplete and outdated annotation tables, which often rely on older genome and transcriptome versions that differ substantially from up-to-date sequence databases. Here, we present the Re-Annotator, a re-annotation pipeline for microarray probe sequences. It is primarily designed for gene expression microarrays but can also be adapted to other types of microarrays. The Re-Annotator uses a custom-built mRNA reference database to identify the positions of gene expression array probe sequences. We applied Re-Annotator to the Illumina Human-HT12 v4 microarray platform and found that about one quarter (25%) of the probes differed from the manufacturer’s annotation. In further computational experiments on experimental gene expression data, we compared Re-Annotator to another probe re-annotation tool, ReMOAT, and found that Re-Annotator provided an improved re-annotation of microarray probes. A thorough re-annotation of probe information is crucial to any microarray analysis. The Re-Annotator pipeline is freely available at along with re-annotated files for Illumina microarrays HumanHT-12 v3/v4 and MouseRef-8 v2.
ACCESSION #
110116879

 

Related Articles

  • Dimension Reduction for Mapping mRNA Abundance as Quantitative Traits. Hong Lan; Stoehr, Jonathan P.; Nadler, Samuel T.; Schueler, Kathryn L.; Yandell, Brian S.; Attie, Alan D. // Genetics;Aug2003, Vol. 164 Issue 4, p1607 

    Features a method to reduce the dimensionality for mapping mRNA and gene expression data as quantitative traits. Opportunities to map mRNA abundance to quantitative trait loci throughout the genome; Correlation among the large number of mRNA traits; Validation of the principle of the approach;...

  • Hypermethylation of EDNRB promoter contributes to the risk of colorectal cancer. Cheng Chen; Lingyan Wang; Qi Liao; Yi Huang; Huadan Ye; Fei Chen; Leiting Xu; Meng Ye; Shiwei Duan // Diagnostic Pathology;2013, Vol. 8 Issue 1, p1 

    Objective Colorectal cancer (CRC) is one of the most common digestive malignancies in the world. EDNRB is a new candidate tumor suppressor gene which is often down-regulated or even silenced by promoter hypermethylation in various human cancers. However, the function of EDNRB gene in CRC remains...

  • Expression profile of developmentally important genes between hand-made cloned buffalo embryos produced from reprogramming of donor cell with oocytes extract and selection of recipient cytoplast through brilliant cresyl blue staining and in vitro... EM, Sadeesh; Kataria, Meena; S, Balhara; Yadav, PS // Journal of Assisted Reproduction & Genetics;Nov2014, Vol. 31 Issue 11, p1541 

    Purpose: To compare the expression profile of developmentally important genes between hand-made cloned buffalo embryos produced from reprogramming of donor cell with oocyte extracts and selection of recipient cytoplast through brilliant cresyl blue staining and in vitro fertilized (IVF) embryos....

  • MicroRNAs Targeting Oncogenes Are Down-Regulated in Pancreatic Malignant Transformation from Benign Tumors. Jiao, Long R.; Frampton, Adam E.; Jacob, Jimmy; Pellegrino, Loredana; Krell, Jonathan; Giamas, Georgios; Tsim, Nicole; Vlavianos, Panagiotis; Cohen, Patrizia; Ahmad, Raida; Keller, Andreas; Habib, Nagy A.; Stebbing, Justin; Castellano, Leandro // PLoS ONE;Feb2012, Vol. 7 Issue 2, p1 

    Background: MicroRNA (miRNA) expression profiles have been described in pancreatic ductal adenocarcinoma (PDAC), but these have not been compared with pre-malignant pancreatic tumors. We wished to compare the miRNA expression signatures in pancreatic benign cystic tumors (BCT) of low and...

  • Hydroxyapatite Modulates mRNA Expression Profiles in Cultured Osteocytes. Hamamura, Kazunori; Zhao, Liming; Jiang, Chang; Tanjung, Nancy; Swarnkar, Gaurav; Yokota, Hiroki // Cellular & Molecular Bioengineering;Jun2012, Vol. 5 Issue 2, p217 

    Osteocytes in vivo present a unique pattern of gene expression necessary for bone remodeling and mineral metabolism. Genes expressed in osteocytes such as Sost and fibroblast growth factor 23 (FGF23) are essential for load-driven bone formation and regulation of phosphate in the serum,...

  • Time-Course Analysis of Cyanobacterium Transcriptome: Detecting Oscillatory Genes. Layana, Carla; Diambra, Luis // PLoS ONE;2011, Vol. 6 Issue 10, p1 

    The microarray technique allows the simultaneous measurements of the expression levels of thousands of mRNAs. By mining these data one can identify the dynamics of the gene expression time series. The detection of genes that are periodically expressed is an important step that allows us to study...

  • MicroRNAs Targeting Oncogenes Are Down-Regulated in Pancreatic Malignant Transformation from Benign Tumors. Jiao, Long R.; Frampton, Adam E.; Jacob, Jimmy; Pellegrino, Loredana; Krell, Jonathan; Giamas, Georgios; Tsim, Nicole; Vlavianos, Panagiotis; Cohen, Patrizia; Ahmad, Raida; Keller, Andreas; Habib, Nagy A.; Stebbing, Justin; Castellano, Leandro // PLoS ONE;Feb2012, Vol. 7 Issue 2, p1 

    Background: MicroRNA (miRNA) expression profiles have been described in pancreatic ductal adenocarcinoma (PDAC), but these have not been compared with pre-malignant pancreatic tumors. We wished to compare the miRNA expression signatures in pancreatic benign cystic tumors (BCT) of low and...

  • Protein expression based multimarker analysis of breast cancer samples. Presson, Angela P.; Yoon, Nam K.; Bagryanova, Lora; Mah, Vei; Alavi, Mohammad; Maresh, Erin L.; Rajasekaran, Ayyappan K.; Goodglick, Lee; Chia, David; Horvath, Steve // BMC Cancer;2011, Vol. 11 Issue 1, p230 

    Background: Tissue microarray (TMA) data are commonly used to validate the prognostic accuracy of tumor markers. For example, breast cancer TMA data have led to the identification of several promising prognostic markers of survival time. Several studies have shown that TMA data can also be used...

  • Validation and implementation of a method for microarray gene expression profiling of minor B-cell subpopulations in man. Bergkvist, Kim Steve; Nyegaard, Mette; Bøgsted, Martin; Schmitz, Alexander; Bødker, Julie Støve; Rasmussen, Simon Mylius; Perez-Andres, Martin; Falgreen, Steffen; Bilgrau, Anders Ellern; Kjeldsen, Malene Krag; Gaihede, Michael; Nørgaard, Martin Agge; Bæch, John; Grønholdt, Marie-Louise; Jensen, Frank Svendsen; Johansen, Preben; Dybkær, Karen; Johnsen, Hans Erik // BMC Immunology; 

    Background This report describes a method for the generation of global gene expression profiles from low frequent B-cell subsets by using fluorescence-activated cell sorting and RNA amplification. However, some of the differentiating compartments involve a low number of cells and therefore it is...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics